HEADER OXIDOREDUCTASE 24-JUN-03 1UH5 TITLE CRYSTAL STRUCTURE OF ENOYL-ACP REDUCTASE WITH TRICLOSAN AT TITLE 2 2.2ANGSTROMS COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENOYL-ACP REDUCTASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 96-424; COMPND 5 SYNONYM: ENOYL-ACYL CARRIER REDUCTASE; COMPND 6 EC: 1.3.1.9; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PLASMODIUM FALCIPARUM; SOURCE 3 ORGANISM_COMMON: MALARIA PARASITE P. FALCIPARUM; SOURCE 4 ORGANISM_TAXID: 5833; SOURCE 5 GENE: FABI; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 DE3; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28A(+) KEYWDS FABI, TRICLOSAN, P.FALCIPARUM, ENOYL-ACP REDUCTASE, NAD+, KEYWDS 2 OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR P.L.SWARNAMUKHI,M.KAPOOR,N.SUROLIA,A.SUROLIA,K.SUGUNA REVDAT 5 25-OCT-23 1UH5 1 REMARK REVDAT 4 29-NOV-17 1UH5 1 HELIX REVDAT 3 13-JUL-11 1UH5 1 VERSN REVDAT 2 24-FEB-09 1UH5 1 VERSN REVDAT 1 28-SEP-04 1UH5 0 JRNL AUTH L.S.PIDUGU,M.KAPOOR,N.SUROLIA,A.SUROLIA,K.SUGUNA JRNL TITL STRUCTURAL BASIS FOR THE VARIATION IN TRICLOSAN AFFINITY TO JRNL TITL 2 ENOYL REDUCTASES. JRNL REF J.MOL.BIOL. V. 343 147 2004 JRNL REFN ISSN 0022-2836 JRNL PMID 15381426 JRNL DOI 10.1016/J.JMB.2004.08.033 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.KAPOOR,P.L.SWARNAMUKHI,N.SUROLIA,K.SUGUNA,A.SUROLIA REMARK 1 TITL KINETIC AND STRUCTURAL ANALYSIS OF THE INCREASED AFFINITY OF REMARK 1 TITL 2 ENOYL-ACP (ACYL-CARRIER PROTEIN) REDUCTASE FOR TRICLOSAN IN REMARK 1 TITL 3 THE PRESENCE OF NAD+ REMARK 1 REF BIOCHEM.J. V. 381 725 2004 REMARK 1 REFN ISSN 0264-6021 REMARK 1 PMID 15125687 REMARK 1 DOI 10.1042/BJ20040228 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 0.9 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 17.21 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 543563.280 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.6 REMARK 3 NUMBER OF REFLECTIONS : 34648 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.180 REMARK 3 FREE R VALUE : 0.211 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 6.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2216 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.004 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.34 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 5588 REMARK 3 BIN R VALUE (WORKING SET) : 0.1970 REMARK 3 BIN FREE R VALUE : 0.2340 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 6.50 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 391 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.012 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4321 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 122 REMARK 3 SOLVENT ATOMS : 164 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 26.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.33000 REMARK 3 B22 (A**2) : 3.33000 REMARK 3 B33 (A**2) : -6.66000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.21 REMARK 3 ESD FROM SIGMAA (A) : 0.15 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.25 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.19 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.90 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.010 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 2.060 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 3.120 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 4.040 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 5.270 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.39 REMARK 3 BSOL : 84.31 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : TCL1.PARAM REMARK 3 PARAMETER FILE 4 : NAD1.PARAM REMARK 3 PARAMETER FILE 5 : ION.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : TCL1.TOP REMARK 3 TOPOLOGY FILE 4 : NAD1.TOP REMARK 3 TOPOLOGY FILE 5 : ION.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1UH5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 26-JUN-03. REMARK 100 THE DEPOSITION ID IS D_1000005819. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-OCT-02 REMARK 200 TEMPERATURE (KELVIN) : 298.0 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : OSMIC MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 37772 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 200 DATA REDUNDANCY : 7.200 REMARK 200 R MERGE (I) : 0.10100 REMARK 200 R SYM (I) : 0.10900 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 20.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.3 REMARK 200 DATA REDUNDANCY IN SHELL : 7.00 REMARK 200 R MERGE FOR SHELL (I) : 0.35800 REMARK 200 R SYM FOR SHELL (I) : 0.38800 REMARK 200 <I/SIGMA(I)> FOR SHELL : 7.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1ENO REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.87 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: SODIUM ACETATE, AMMONIUM SULFATE, PH REMARK 280 5.6, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 41.82950 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 66.50800 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 66.50800 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 62.74425 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 66.50800 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 66.50800 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 20.91475 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 66.50800 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 66.50800 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 62.74425 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 66.50800 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 66.50800 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 20.91475 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 41.82950 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE FUNCTIONAL TETRAMER IS GENERATED BY THE TWO FOLD AXIS: - REMARK 300 Y+A, -X+B, -Z+C/2 REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 23950 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 36200 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -213.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 -1.000000 0.000000 133.01600 REMARK 350 BIOMT2 2 -1.000000 0.000000 0.000000 133.01600 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 41.82950 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 325 REMARK 465 LEU A 326 REMARK 465 ASN A 327 REMARK 465 ASN A 328 REMARK 465 THR A 329 REMARK 465 TYR A 330 REMARK 465 GLU A 331 REMARK 465 ASN A 332 REMARK 465 ASN A 333 REMARK 465 THR A 334 REMARK 465 ASN A 335 REMARK 465 GLN A 336 REMARK 465 ASN A 337 REMARK 465 LYS A 338 REMARK 465 ASN A 339 REMARK 465 ARG A 340 REMARK 465 ASN A 341 REMARK 465 ARG A 342 REMARK 465 HIS A 343 REMARK 465 ASP A 344 REMARK 465 VAL A 345 REMARK 465 HIS A 346 REMARK 465 ASN A 347 REMARK 465 ILE A 348 REMARK 465 MET A 349 REMARK 465 ASN A 350 REMARK 465 ASN A 351 REMARK 465 SER A 352 REMARK 465 GLY A 353 REMARK 465 GLU A 354 REMARK 465 LYS A 355 REMARK 465 GLU A 356 REMARK 465 GLU A 357 REMARK 465 LYS A 358 REMARK 465 LYS A 359 REMARK 465 ILE A 360 REMARK 465 SER A 361 REMARK 465 ALA A 362 REMARK 465 SER A 363 REMARK 465 GLN A 364 REMARK 465 ASN A 365 REMARK 465 TYR A 366 REMARK 465 LYS B 325 REMARK 465 LEU B 326 REMARK 465 ASN B 327 REMARK 465 ASN B 328 REMARK 465 THR B 329 REMARK 465 TYR B 330 REMARK 465 GLU B 331 REMARK 465 ASN B 332 REMARK 465 ASN B 333 REMARK 465 THR B 334 REMARK 465 ASN B 335 REMARK 465 GLN B 336 REMARK 465 ASN B 337 REMARK 465 LYS B 338 REMARK 465 ASN B 339 REMARK 465 ARG B 340 REMARK 465 ASN B 341 REMARK 465 ARG B 342 REMARK 465 HIS B 343 REMARK 465 ASP B 344 REMARK 465 VAL B 345 REMARK 465 HIS B 346 REMARK 465 ASN B 347 REMARK 465 ILE B 348 REMARK 465 MET B 349 REMARK 465 ASN B 350 REMARK 465 ASN B 351 REMARK 465 SER B 352 REMARK 465 GLY B 353 REMARK 465 GLU B 354 REMARK 465 LYS B 355 REMARK 465 GLU B 356 REMARK 465 GLU B 357 REMARK 465 LYS B 358 REMARK 465 LYS B 359 REMARK 465 ILE B 360 REMARK 465 SER B 361 REMARK 465 ALA B 362 REMARK 465 SER B 363 REMARK 465 GLN B 364 REMARK 465 ASN B 365 REMARK 465 TYR B 366 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASN A 96 CG OD1 ND2 REMARK 470 GLU A 97 CB CG CD OE1 OE2 REMARK 470 LYS A 125 CG CD CE NZ REMARK 470 LYS A 140 CG CD CE NZ REMARK 470 LYS A 143 CG CD CE NZ REMARK 470 LYS A 146 CG CD CE NZ REMARK 470 ASP A 154 CG OD1 OD2 REMARK 470 LYS A 155 CG CD CE NZ REMARK 470 ASP A 156 CB CG OD1 OD2 REMARK 470 LYS A 157 CG CD CE NZ REMARK 470 ASN A 160 CG OD1 ND2 REMARK 470 GLU A 179 CB CG CD OE1 OE2 REMARK 470 GLU A 180 CG CD OE1 OE2 REMARK 470 LYS A 182 CG CD CE NZ REMARK 470 ASN A 183 CG OD1 ND2 REMARK 470 LYS A 185 CG CD CE NZ REMARK 470 ARG A 186 CB CG CD NE CZ NH1 NH2 REMARK 470 ASN A 188 CG OD1 ND2 REMARK 470 LYS A 220 CG CD CE NZ REMARK 470 LYS A 232 CG CD CE NZ REMARK 470 ASN A 302 CG OD1 ND2 REMARK 470 ARG A 318 CB CG CD NE CZ NH1 NH2 REMARK 470 ASN A 324 CG OD1 ND2 REMARK 470 GLU A 374 CG CD OE1 OE2 REMARK 470 ARG A 383 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 385 CG CD CE NZ REMARK 470 ARG A 401 CG CD NE CZ NH1 NH2 REMARK 470 ASN B 96 CG OD1 ND2 REMARK 470 GLU B 97 CB CG CD OE1 OE2 REMARK 470 LYS B 125 CG CD CE NZ REMARK 470 LYS B 140 CG CD CE NZ REMARK 470 LYS B 143 CG CD CE NZ REMARK 470 LYS B 146 CG CD CE NZ REMARK 470 ASN B 149 CG OD1 ND2 REMARK 470 ASP B 154 CG OD1 OD2 REMARK 470 LYS B 155 CG CD CE NZ REMARK 470 ASP B 156 CB CG OD1 OD2 REMARK 470 LYS B 157 CG CD CE NZ REMARK 470 LYS B 158 CG CD CE NZ REMARK 470 ASN B 160 CG OD1 ND2 REMARK 470 GLU B 179 CG CD OE1 OE2 REMARK 470 LYS B 182 CG CD CE NZ REMARK 470 ASN B 183 CG OD1 ND2 REMARK 470 ASN B 188 CG OD1 ND2 REMARK 470 MET B 189 CB CG SD CE REMARK 470 GLN B 191 CG CD OE1 NE2 REMARK 470 GLN B 204 CG CD OE1 NE2 REMARK 470 LYS B 232 CG CD CE NZ REMARK 470 ASN B 302 CG OD1 ND2 REMARK 470 ARG B 318 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 374 CG CD OE1 OE2 REMARK 470 ARG B 401 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 97 5.21 118.23 REMARK 500 ASP A 107 -165.15 -169.15 REMARK 500 ASP A 154 -151.63 46.48 REMARK 500 LYS A 155 -114.56 -70.13 REMARK 500 ASP A 414 28.10 -142.64 REMARK 500 PHE A 421 -76.98 -117.59 REMARK 500 GLU B 97 15.36 88.50 REMARK 500 ASP B 107 -168.54 -174.86 REMARK 500 ASP B 154 -135.27 38.61 REMARK 500 ASP B 156 -16.60 74.52 REMARK 500 ASP B 414 33.33 -148.92 REMARK 500 REMARK 500 REMARK: NULL REMARK 750 REMARK 750 TURN REMARK 750 DETERMINATION METHOD: AUTHOR DETERMINED REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TCL A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TCL B 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD B 601 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1ENO RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ENOYL-ACP-REDUCTASE FROM BRASSICA NAPUS REMARK 900 RELATED ID: 1NHG RELATED DB: PDB REMARK 900 CRYSTAL CRYSTAL STRUCTURE OF ENOYL-ACP-REDUCTASE WITH TRICLOSAN DBREF 1UH5 A 96 424 UNP Q6LFB9 Q6LFB9_PLAF7 96 424 DBREF 1UH5 B 96 424 UNP Q6LFB9 Q6LFB9_PLAF7 96 424 SEQRES 1 A 329 ASN GLU ASP ILE CYS PHE ILE ALA GLY ILE GLY ASP THR SEQRES 2 A 329 ASN GLY TYR GLY TRP GLY ILE ALA LYS GLU LEU SER LYS SEQRES 3 A 329 ARG ASN VAL LYS ILE ILE PHE GLY ILE TRP PRO PRO VAL SEQRES 4 A 329 TYR ASN ILE PHE MET LYS ASN TYR LYS ASN GLY LYS PHE SEQRES 5 A 329 ASP ASN ASP MET ILE ILE ASP LYS ASP LYS LYS MET ASN SEQRES 6 A 329 ILE LEU ASP MET LEU PRO PHE ASP ALA SER PHE ASP THR SEQRES 7 A 329 ALA ASN ASP ILE ASP GLU GLU THR LYS ASN ASN LYS ARG SEQRES 8 A 329 TYR ASN MET LEU GLN ASN TYR THR ILE GLU ASP VAL ALA SEQRES 9 A 329 ASN LEU ILE HIS GLN LYS TYR GLY LYS ILE ASN MET LEU SEQRES 10 A 329 VAL HIS SER LEU ALA ASN ALA LYS GLU VAL GLN LYS ASP SEQRES 11 A 329 LEU LEU ASN THR SER ARG LYS GLY TYR LEU ASP ALA LEU SEQRES 12 A 329 SER LYS SER SER TYR SER LEU ILE SER LEU CYS LYS TYR SEQRES 13 A 329 PHE VAL ASN ILE MET LYS PRO GLN SER SER ILE ILE SER SEQRES 14 A 329 LEU THR TYR HIS ALA SER GLN LYS VAL VAL PRO GLY TYR SEQRES 15 A 329 GLY GLY GLY MET SER SER ALA LYS ALA ALA LEU GLU SER SEQRES 16 A 329 ASP THR ARG VAL LEU ALA TYR HIS LEU GLY ARG ASN TYR SEQRES 17 A 329 ASN ILE ARG ILE ASN THR ILE SER ALA GLY PRO LEU LYS SEQRES 18 A 329 SER ARG ALA ALA THR ALA ILE ASN LYS LEU ASN ASN THR SEQRES 19 A 329 TYR GLU ASN ASN THR ASN GLN ASN LYS ASN ARG ASN ARG SEQRES 20 A 329 HIS ASP VAL HIS ASN ILE MET ASN ASN SER GLY GLU LYS SEQRES 21 A 329 GLU GLU LYS LYS ILE SER ALA SER GLN ASN TYR THR PHE SEQRES 22 A 329 ILE ASP TYR ALA ILE GLU TYR SER GLU LYS TYR ALA PRO SEQRES 23 A 329 LEU ARG GLN LYS LEU LEU SER THR ASP ILE GLY SER VAL SEQRES 24 A 329 ALA SER PHE LEU LEU SER ARG GLU SER ARG ALA ILE THR SEQRES 25 A 329 GLY GLN THR ILE TYR VAL ASP ASN GLY LEU ASN ILE MET SEQRES 26 A 329 PHE LEU PRO ASP SEQRES 1 B 329 ASN GLU ASP ILE CYS PHE ILE ALA GLY ILE GLY ASP THR SEQRES 2 B 329 ASN GLY TYR GLY TRP GLY ILE ALA LYS GLU LEU SER LYS SEQRES 3 B 329 ARG ASN VAL LYS ILE ILE PHE GLY ILE TRP PRO PRO VAL SEQRES 4 B 329 TYR ASN ILE PHE MET LYS ASN TYR LYS ASN GLY LYS PHE SEQRES 5 B 329 ASP ASN ASP MET ILE ILE ASP LYS ASP LYS LYS MET ASN SEQRES 6 B 329 ILE LEU ASP MET LEU PRO PHE ASP ALA SER PHE ASP THR SEQRES 7 B 329 ALA ASN ASP ILE ASP GLU GLU THR LYS ASN ASN LYS ARG SEQRES 8 B 329 TYR ASN MET LEU GLN ASN TYR THR ILE GLU ASP VAL ALA SEQRES 9 B 329 ASN LEU ILE HIS GLN LYS TYR GLY LYS ILE ASN MET LEU SEQRES 10 B 329 VAL HIS SER LEU ALA ASN ALA LYS GLU VAL GLN LYS ASP SEQRES 11 B 329 LEU LEU ASN THR SER ARG LYS GLY TYR LEU ASP ALA LEU SEQRES 12 B 329 SER LYS SER SER TYR SER LEU ILE SER LEU CYS LYS TYR SEQRES 13 B 329 PHE VAL ASN ILE MET LYS PRO GLN SER SER ILE ILE SER SEQRES 14 B 329 LEU THR TYR HIS ALA SER GLN LYS VAL VAL PRO GLY TYR SEQRES 15 B 329 GLY GLY GLY MET SER SER ALA LYS ALA ALA LEU GLU SER SEQRES 16 B 329 ASP THR ARG VAL LEU ALA TYR HIS LEU GLY ARG ASN TYR SEQRES 17 B 329 ASN ILE ARG ILE ASN THR ILE SER ALA GLY PRO LEU LYS SEQRES 18 B 329 SER ARG ALA ALA THR ALA ILE ASN LYS LEU ASN ASN THR SEQRES 19 B 329 TYR GLU ASN ASN THR ASN GLN ASN LYS ASN ARG ASN ARG SEQRES 20 B 329 HIS ASP VAL HIS ASN ILE MET ASN ASN SER GLY GLU LYS SEQRES 21 B 329 GLU GLU LYS LYS ILE SER ALA SER GLN ASN TYR THR PHE SEQRES 22 B 329 ILE ASP TYR ALA ILE GLU TYR SER GLU LYS TYR ALA PRO SEQRES 23 B 329 LEU ARG GLN LYS LEU LEU SER THR ASP ILE GLY SER VAL SEQRES 24 B 329 ALA SER PHE LEU LEU SER ARG GLU SER ARG ALA ILE THR SEQRES 25 B 329 GLY GLN THR ILE TYR VAL ASP ASN GLY LEU ASN ILE MET SEQRES 26 B 329 PHE LEU PRO ASP HET TCL A 502 17 HET NAD A 501 44 HET TCL B 602 17 HET NAD B 601 44 HETNAM TCL TRICLOSAN HETNAM NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE FORMUL 3 TCL 2(C12 H7 CL3 O2) FORMUL 4 NAD 2(C21 H27 N7 O14 P2) FORMUL 7 HOH *164(H2 O) HELIX 1 1 GLY A 110 ARG A 122 1 13 HELIX 2 2 TRP A 131 PRO A 133 5 3 HELIX 3 3 VAL A 134 ASN A 144 1 11 HELIX 4 4 ASP A 148 ASP A 150 5 3 HELIX 5 5 THR A 173 ILE A 177 5 5 HELIX 6 6 ASP A 178 ASN A 183 1 6 HELIX 7 7 ASN A 184 MET A 189 1 6 HELIX 8 8 THR A 194 GLY A 207 1 14 HELIX 9 9 ASP A 225 THR A 229 5 5 HELIX 10 10 SER A 230 SER A 242 1 13 HELIX 11 11 SER A 242 VAL A 253 1 12 HELIX 12 12 TYR A 267 GLN A 271 5 5 HELIX 13 13 GLY A 280 ASN A 304 1 25 HELIX 14 14 ALA A 319 ILE A 323 5 5 HELIX 15 15 THR A 367 ALA A 380 1 14 HELIX 16 16 LEU A 387 SER A 400 1 14 HELIX 17 17 ARG A 401 ARG A 404 5 4 HELIX 18 18 GLY A 416 MET A 420 5 5 HELIX 19 19 GLY B 110 ARG B 122 1 13 HELIX 20 20 TRP B 131 PRO B 133 5 3 HELIX 21 21 VAL B 134 ASN B 144 1 11 HELIX 22 22 ASP B 148 ASP B 150 5 3 HELIX 23 23 THR B 173 ILE B 177 5 5 HELIX 24 24 ASP B 178 ASN B 184 1 7 HELIX 25 25 THR B 194 GLY B 207 1 14 HELIX 26 26 ASP B 225 THR B 229 5 5 HELIX 27 27 SER B 230 SER B 242 1 13 HELIX 28 28 SER B 242 VAL B 253 1 12 HELIX 29 29 TYR B 267 GLN B 271 5 5 HELIX 30 30 GLY B 280 ASN B 304 1 25 HELIX 31 31 ARG B 318 ASN B 324 5 7 HELIX 32 32 THR B 367 ALA B 380 1 14 HELIX 33 33 LEU B 387 SER B 400 1 14 HELIX 34 34 ARG B 401 ARG B 404 5 4 HELIX 35 35 GLY B 416 MET B 420 5 5 SHEET 1 A 7 ILE A 161 PRO A 166 0 SHEET 2 A 7 LYS A 125 ILE A 130 1 N ILE A 130 O LEU A 165 SHEET 3 A 7 ILE A 99 ALA A 103 1 N ILE A 102 O ILE A 127 SHEET 4 A 7 ILE A 209 HIS A 214 1 O VAL A 213 N ALA A 103 SHEET 5 A 7 MET A 256 THR A 266 1 O ILE A 263 N HIS A 214 SHEET 6 A 7 ARG A 306 ALA A 312 1 O ILE A 310 N SER A 264 SHEET 7 A 7 THR A 410 VAL A 413 1 O ILE A 411 N THR A 309 SHEET 1 B 2 ILE A 152 ILE A 153 0 SHEET 2 B 2 LYS A 157 LYS A 158 -1 O LYS A 157 N ILE A 153 SHEET 1 C 7 ILE B 161 PRO B 166 0 SHEET 2 C 7 LYS B 125 ILE B 130 1 N ILE B 130 O LEU B 165 SHEET 3 C 7 ILE B 99 ALA B 103 1 N CYS B 100 O LYS B 125 SHEET 4 C 7 ILE B 209 HIS B 214 1 O VAL B 213 N ALA B 103 SHEET 5 C 7 MET B 256 THR B 266 1 O ILE B 263 N HIS B 214 SHEET 6 C 7 ARG B 306 ALA B 312 1 O ILE B 310 N SER B 264 SHEET 7 C 7 THR B 410 VAL B 413 1 O ILE B 411 N THR B 309 SHEET 1 D 2 ILE B 152 ILE B 153 0 SHEET 2 D 2 LYS B 157 LYS B 158 -1 O LYS B 157 N ILE B 153 SITE 1 AC1 9 ALA A 217 ASN A 218 ALA A 219 TYR A 267 SITE 2 AC1 9 TYR A 277 ALA A 319 ALA A 320 ILE A 323 SITE 3 AC1 9 NAD A 501 SITE 1 AC2 8 ALA B 217 ASN B 218 ALA B 219 TYR B 267 SITE 2 AC2 8 TYR B 277 ALA B 319 NAD B 601 HOH B 677 SITE 1 AC3 28 GLY A 104 ILE A 105 GLY A 106 GLY A 110 SITE 2 AC3 28 TYR A 111 TRP A 131 PHE A 167 ASP A 168 SITE 3 AC3 28 ALA A 169 SER A 170 SER A 215 LEU A 216 SITE 4 AC3 28 ALA A 217 ASN A 218 LEU A 265 THR A 266 SITE 5 AC3 28 LYS A 285 ALA A 312 GLY A 313 PRO A 314 SITE 6 AC3 28 LEU A 315 SER A 317 ALA A 319 TCL A 502 SITE 7 AC3 28 HOH A 509 HOH A 523 HOH A 571 HOH A 572 SITE 1 AC4 28 GLY B 104 ILE B 105 GLY B 106 GLY B 110 SITE 2 AC4 28 TYR B 111 TRP B 131 PHE B 167 ASP B 168 SITE 3 AC4 28 ALA B 169 SER B 170 SER B 215 LEU B 216 SITE 4 AC4 28 ALA B 217 ASN B 218 LEU B 265 THR B 266 SITE 5 AC4 28 LYS B 285 ALA B 312 GLY B 313 PRO B 314 SITE 6 AC4 28 LEU B 315 SER B 317 ALA B 319 TCL B 602 SITE 7 AC4 28 HOH B 621 HOH B 623 HOH B 636 HOH B 677 CRYST1 133.016 133.016 83.659 90.00 90.00 90.00 P 43 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007518 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007518 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011953 0.00000